# Gilead Sciences, Inc.: Form 4, filed Jun 28, 2023

- Company: [Gilead Sciences, Inc.](/companies/gild.md) (CIK 882095)
- Form: 4
- Filed: 2023-06-28
- Accepted by EDGAR: Jun 28, 2023, 17:17 ET
- Period: 2023-06-27
- Accession: 0001062993-23-014111
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/882095/000106299323014111/xslF345X04/form4.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/882095/000106299323014111/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/882095/000106299323014111/xslF345X04/form4.xml

Filed Jun 28, 2023.
Source: SEC EDGAR, the filing index for accession 0001062993-23-014111. Last ingested by Listed: Nov 2, 2026, 20:45 ET. No prices; not investment advice.